Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 8/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.47 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.36 |
| ▸ | Q9HBH1 | 1/20 | 0.35 | |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | CPN1 | P15169 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2871469 | 0.94 | CPB2 (0.50) | CA1CA2FOLH1CPB2ZDHHC7 | |
| SCHEMBL2871738 | 0.87 | CA1 (0.45) | CA1CA2FOLH1CPB2ZDHHC7 | |
| SCHEMBL3238313 | 0.86 | CA2 (0.71) | CA1CA2FOLH1CPB2ZDHHC7 | |
| SCHEMBL2879991 | 0.82 | — | — | |
| SCHEMBL2875679 | 0.82 | CPB2 (0.69) | CA1CA2FOLH1CPB2HSD17B10 | |
| SCHEMBL15166984 | 0.78 | FOLH1 (0.41) | CA1CA2FOLH1ZDHHC7TSHR | |
| SCHEMBL2877742 | 0.78 | CA1 (0.48) | CA1CA2FOLH1CPB2ZDHHC7 | |
| SCHEMBL9814818 | 0.78 | SLC1A1 (0.47) | CA1CA2FOLH1CPB2TSHR | |
| SCHEMBL10962217 | 0.77 | FOLH1 (0.40) | CA1CA2FOLH1ZDHHC7TSHR | |
| SCHEMBL2880166 | 0.76 | CPB2 (0.72) | CA1CA2FOLH1CPB2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1570835-B1 | Composition for the permanent deformation of the hair comprising at least one carboxydithiol | OREAL (FR) | 2010-10-20 | — | — | EP | claimed |
| US-20050208007-A1 | Composition to permanently reshape the hair containing at least one carboxydithiol | L'OREAL S.A. (FR) | 2005-09-22 | — | — | US | claimed |
| US-20050208007-A1 | Composition to permanently reshape the hair containing at least one carboxydithiol | L'OREAL S.A. (FR) | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050208007-A1 | Composition to permanently reshape the hair containing at least one carboxydithiol | CTH, BHMT2, CRAT | CA1 913/4885CA2 409/4885FOLH1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.